TrialLancet (London, England)2016

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.

Patricia A Ganz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.